• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Aug21
Ascentage Pharma released FY2025 Q1 earnings on August 20 (EST), actual revenue USD 16.09 M, actual EPS USD -0.4763
03:00
Aug20
Ascentage Pharma released FY2025 Semi-Annual Earnings on August 20 Pre-Market EST, with actual revenue of USD 32.38 M and EPS of USD -0.9587
13:30
Ascentage Pharma released FY2025 Q2 earnings on August 20 Pre-Market EST, actual revenue USD 16.29 M, actual EPS USD -0.4824
13:30
Aug12
Ascentage Pharma to release FY2025 Semi-Annual earnings report on August 19, 2025, during market hours (EST)
00:08
Jun27
Aspect Pharma Announces New Restricted Stock Units Plan
12:55
Mar28
Ascentage Pharma released FY2024 9 Months Earnings on March 27 (EST), with actual revenue of 124.91 M USD and EPS of -0.2154 USD
03:00

Schedules & Filings

Schedules
Filings
Aug20
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 16.29 M, Net Income -41.19 M, EPS -0.4824

Aug19
Earning Release(EST)

FY2025 Semi-Annual Earning Release

Mar27
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 10.75 M, Net Income -38.94 M, EPS -0.4986

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More